Ogiso Life Sciences Private Limited

Ogiso Life Sciences Private Limited - pharma in Agra, Uttar Pradesh, India. FY 2026 financials and compliance.
CIN U24304UP2017PTC094297 Incorporated 21 June 2017 ROC Kanpur HQ Agra, Uttar Pradesh, India
Active Private Limited Company pharma
Data last updated
Revenue · FY 2025
₹11.25 Cr
▼ 5.00% YoY
EBITDA · FY 2025
Locked
In full report
Net profit · FY 2025
Locked
In full report
Authorised capital
₹70 Lakh
Registered with MCA
Paid-up capital
₹70 Lakh
Issued & subscribed
Open charges
₹6.43 Cr
Satisfied ₹42 Lakh
Company age
9 yrs
Est. 2017
Employees · EPFO
22
Latest available

About Ogiso Life Sciences Private Limited

Data last updated: 11 January 2026

Ogiso Life Sciences Private Limited is a private limited company based in Agra, Uttar Pradesh, India. It specialises in drug formulation and development, a part of the broader pharmaceuticals sector. Incorporated on 21 June 2017, the company has been in operation for over 9 years.

Registered with ROC Kanpur under CIN U24304UP2017PTC094297.

Capital: an authorised share capital of ₹70 Lakh and a paid-up capital of ₹70 Lakh. It is led by directors Saurabh Sawhney and Jyoti Prasad.

Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 17/37B/10 Banaras Bank Phatak Phulatti, Agra, Uttar Pradesh, India – 282002.

As per the financials filed for FY 2025, the company reported a revenue of ₹11.25 Cr, a decline of 5% compared to the previous year.

The company has a workforce of approximately 22 employees as per the latest available data.

The company is associated with 2 brands - Ogiso, Ogiso Lifesciences. As per MCA filings, the company has open charges of ₹6.43 Cr and satisfied charges of ₹42 Lakh on record.

The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website ogisolifesciences.in.

Company Details of Ogiso Life Sciences Private Limited
CIN U24304UP2017PTC094297
Registration Number 094297
Incorporation Date 21 June 2017
ROC Kanpur
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Social Media
  • Registered Address
    17/37B/10 Banaras Bank Phatak Phulatti, Agra, Uttar Pradesh, India – 282002
  • Industry
    Pharma, Drug Formulation & Development
Company report
Ogiso Life Sciences Private Limited - full intelligence report
  • Historical Financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Litigation, compliance and MCA filings
  • PDF report delivered after checkout
₹799 ₹999 20% off
Secure checkout · GST invoice included

Unlock the full Ogiso Life Sciences Private Limited report

Financials, compliance, directors, charges, ownership and filings for Ogiso Life Sciences Private Limited in one report.

10-year financials Directors & ownership Charges & compliance

Associated Brands with Ogiso Life Sciences Private Limited

Ogiso Life Sciences Private Limited operates two associated brands: Ogiso and OGISO Lifesciences. These brands represent Ogiso Life Sciences Private Limited's diversified market presence and brand portfolio.

Brand Description Website
Ogiso Life Sciences produces pharmaceutical products through manufacturing and research. ogisolifesciences.in
Pharmaceutical manufacturing, product range, and franchise services in India. ogisolifesciences.com

Competitors & Alternatives of Ogiso Life Sciences Private Limited

Brands and companies operating in the same space as Ogiso Life Sciences Private Limited include Merck, Roivant Sciences, AbbVie and 7 more.

Competitor Description Location Founded
Merck Merck Pharmaceutical products are manufactured and marketed worldwide. Kenilworth, United Kingdom, United Kingdom 1891
Roivant Sciences Roivant Sciences Therapeutics for neurology, oncology, rare, and endocrinology diseases are developed. New York, United States, United States 2014
AbbVie AbbVie Biopharmaceutical research and drug development are conducted globally by AbbVie. Chicago, United States, United States 2012
Lilly Lilly Traditional pharmaceutical medicines are developed for multiple health fields. United States 1876
Gilead Gilead Developer of medicines to treat HIV/AIDS, liver diseases, cancer & others Foster City, United States, United States 1987
United Therapeutics United Therapeutics Treatments for chronic and life-threatening diseases are developed and commercialized. Silver Spring, United States, United States 1998
Roche Roche Pharmaceuticals and diagnostics kits are developed for various diseases. Basel, Switzerland, Switzerland 1896
MorphoSys MorphoSys Therapeutic antibodies for cancer and other diseases are developed. Planegg, Germany, Germany 1992
Eisai Eisai Drugs for oncology and neurological disorders are developed by Eisai. Tokyo, Japan, Japan 1941
Vertex Pharmaceuticals Vertex Pharmaceuticals Developer of drugs for the treatment of multiple disorders United States 1989

Business Activity of Ogiso Life Sciences Private Limited

Ogiso Life Sciences Private Limited is engaged in the principal business activity of trade, with detailed activities including wholesale trading.

Main Activity Group Code Description of Main Activity Business Activity Code Description of Business Activity Turnover Percentage
G Trade G1 Wholesale Trading Locked
Premium access

Business activity turnover details for Ogiso Life Sciences Private Limited

Turnover contribution percentages and historical activity changes require an active report plan.

  • Turnover contribution
  • Historical classifications
  • Filing-level activity changes

Verified entity values are shown only after access is granted.

Auditor Details of Ogiso Life Sciences Private Limited

Ogiso Life Sciences Private Limited is audited by A. J. ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.

Name Status Appointment Date Cessation Date
A. J. ASSOCIATES Locked Locked Locked
Premium access

Complete auditor history for Ogiso Life Sciences Private Limited

Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.

  • Appointment status
  • Appointment dates
  • Cessation dates
  • Auditor changes

Verified entity values are shown only after access is granted.

Board of Directors of Ogiso Life Sciences Private Limited

Ogiso Life Sciences Private Limited is governed by 2 directors who oversee the company's operations and strategic decisions.

Current Directors
Name Designation Appointment Date Tenure Status
Saurabh Sawhney Director 21 Jun 2017 9 Years 1 Months Current
Jyoti Prasad Director 21 Jun 2017 9 Years 1 Months Current

Financials of Ogiso Life Sciences Private Limited FY 2025 filings available

Ogiso Life Sciences Private Limited reported revenue of ₹11.25 Cr (down 5.00% YoY) for FY 2025.

Revenue · FY 2025
₹11.25 Cr ▼ 5.00%
Premium access

Ten-year financial statements for Ogiso Life Sciences Private Limited

Historical statement values and trend charts require an active report plan.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Verified entity values are shown only after access is granted.

Ownership and Shareholding of Ogiso Life Sciences Private Limited

Premium access

Shareholding and ownership data for Ogiso Life Sciences Private Limited

Promoter, institutional, public, and beneficial ownership values require an active report plan.

  • Ownership categories
  • Historical changes
  • Group structure
  • FII and DII holdings

Verified entity values are shown only after access is granted.

Charges & Borrowings of Ogiso Life Sciences Private Limited

Open charges
₹6.43 Cr
Satisfied charges
₹42 Lakh
Breakdown by lending institutions
Canara Bank₹6.43 Cr
Latest charge details
DateLenderAmountStatus
21 Nov 2025 Canara Bank ₹1.9 Cr Open
20 Dec 2024 Canara Bank ₹1 Cr Open
23 Jan 2018 Canara Bank ₹3.53 Cr Open
26 Oct 2020 Canara Bank ₹42 Lakh Satisfied

Total charge records: 4 View all charges

Employees and EPFO Compliance at Ogiso Life Sciences Private Limited

View historical data on people associated with Ogiso Life Sciences Private Limited, including employment history and EPFO contributions.

Premium access

Employee and EPFO history for Ogiso Life Sciences Private Limited

Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.

  • Monthly headcount
  • PF contributions
  • ECR filing status
  • Establishment history

Verified entity values are shown only after access is granted.

GST Compliance of Ogiso Life Sciences Private Limited

Premium access

GST registrations and filing compliance for Ogiso Life Sciences Private Limited

State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.

  • GSTIN registrations
  • State-wise filing status
  • HSN and SAC details
  • Tax jurisdiction records

Verified entity values are shown only after access is granted.

Credit Ratings, Litigation & Regulatory Alerts for Ogiso Life Sciences Private Limited

Premium access

Credit ratings, litigation, and regulatory alerts for Ogiso Life Sciences Private Limited

Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.

  • Rating history
  • Court and tribunal cases
  • Regulatory alerts
  • Director-linked violations

Verified entity values are shown only after access is granted.

MSME Payment Delays by Ogiso Life Sciences Private Limited

Premium access

MSME payment history for Ogiso Life Sciences Private Limited

Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.

  • Outstanding amounts
  • Delay periods and reasons
  • MSME-1 filing history
  • Vendor payment signals

Verified entity values are shown only after access is granted.

Subsidiaries & Group Companies of Ogiso Life Sciences Private Limited

Premium access

Corporate group structure for Ogiso Life Sciences Private Limited

Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.

  • Parent company
  • Subsidiaries and ownership
  • Associates and joint ventures
  • Entity investments

Verified entity values are shown only after access is granted.

MCA Filings & Documents of Ogiso Life Sciences Private Limited

Premium access

MCA filings and documents for Ogiso Life Sciences Private Limited

Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.

  • Incorporation documents
  • Annual returns and statements
  • Charge filings
  • Complete filing index

Verified entity values are shown only after access is granted.

Recent Activity on Ogiso Life Sciences Private Limited

Charges
17 Dec 2025
A charge registered on 26 Oct 2020 via Charge ID 100399525 with Canara Bank was fully satisfied on 17 Dec 2025.
Charges
21 Nov 2025
A charge with Canara Bank amounted to Rs. 190.00 Lakh with Charge ID 101202473 was registered on 21 Nov 2025.
Activity
30 Sep 2025
Ogiso Life Sciences Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Activity
31 Mar 2025
Ogiso Life Sciences Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kanpur.
Charges
20 Dec 2024
A charge with Canara Bank amounted to Rs. 100.00 Lakh with Charge ID 101053880 was registered on 20 Dec 2024.
Charges
24 Mar 2022
A charge with Canara Bank of Rs. 352.67 Lakh registered on 23 Jan 2018 with Charge ID 100158136 was modified on 24 Mar 2022.

Frequently Asked Questions about Ogiso Life Sciences Private Limited

Ogiso Life Sciences Private Limited is an active private limited company in the pharma sector based in Agra, Uttar Pradesh, India. It was incorporated on 21 June 2017 (9+ years old) and is registered under CIN U24304UP2017PTC094297. The company has 22 employees.

Ogiso Life Sciences Private Limited reported revenue of ₹11.25 Cr for FY 2025 (down 5.00% YoY).

The current directors of Ogiso Life Sciences Private Limited are:

The primary industry of Ogiso Life Sciences Private Limited is pharma. The company specifically operates in drug formulation and development. The company is currently active in this sector.

Ogiso Life Sciences Private Limited can be reached at the registered office: 1737B10 Banaras Bank Phatak Phulatti, Agra, Uttar Pradesh, India – 282002, or through the website ogisolifesciences.in.

The authorised capital is ₹70 Lakh, and the paid-up capital is ₹70 Lakh.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - sourced from MCA, SEBI and RBI filings.

Subscription plans available